- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.21 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 5 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 5 residues within 4Å:- Chain A: V.87, E.89, R.101, D.103, R.113
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain B: D.62, F.64
- Chain C: M.196, R.255
- Ligands: WAV.7
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain B: K.48, V.49, T.50, E.54, Y.56, P.71
Ligand excluded by PLIPEDO.10: 3 residues within 4Å:- Chain C: D.352, F.355
- Ligands: PGE.9
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain C: N.73, F.355, V.469, R.470, R.471
- Chain D: S.107, R.108
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain C: Y.435, R.544
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: K.95, D.96
- Chain C: D.27, R.30, Q.31
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain C: K.477, D.478, D.500, T.538, P.539, I.540
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain C: R.468, D.478, P.480, P.539, W.541
- Chain D: D.71
Ligand excluded by PLIPEDO.19: 2 residues within 4Å:- Chain C: S.186, P.188
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain C: I.395, D.397, Q.398, Q.419, Y.421
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain C: P.441, Q.442
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain C: Q.370, K.373, E.374, E.496
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain C: G.246, F.505, Q.508
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain C: F.363, T.366, I.462, P.464, G.495, E.496
Ligand excluded by PLIPEDO.26: 6 residues within 4Å:- Chain C: E.311, R.315, G.414, A.415, T.449, L.450
Ligand excluded by PLIP- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: H.179, R.181, A.182
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:A.182
- Salt bridges: A:H.179
SO4.28: 6 residues within 4Å:- Chain C: Y.369, K.373, Y.507, Q.508, H.511, F.513
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:Y.369
- Water bridges: C:K.373, C:D.531, C:D.531
- Salt bridges: C:K.373
SO4.31: 4 residues within 4Å:- Chain D: C.114, D.115, C.117, T.132
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:D.115
- 2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x WAV: (1S,2S,3R,4S,5S)-1-(hydroxymethyl)-5-{[2-(2-{[2-nitro-4-(triazan-1-yl)phenyl]amino}ethoxy)ethyl]amino}cyclohexane-1,2,3,4-tetrol(Non-covalent)
WAV.7: 18 residues within 4Å:- Chain C: W.54, D.82, I.83, I.119, W.154, C.155, W.156, W.193, D.195, M.196, F.202, R.255, W.268, D.271, F.304, H.329
- Ligands: PG4.4, EDO.5
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:W.156, C:F.202
- Hydrogen bonds: C:W.156, C:R.255, C:D.271, C:H.329
- Water bridges: C:G.270, C:R.327
- pi-Stacking: C:W.156
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.16: 3 residues within 4Å:- Chain C: Q.385, D.403, R.458
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:Q.385, C:D.403
- Water bridges: C:V.384
PEG.20: 4 residues within 4Å:- Chain C: S.391, I.395, Y.421, T.443
1 PLIP interactions:1 interactions with chain C- Water bridges: C:T.443
PEG.29: 5 residues within 4Å:- Chain C: A.110, S.111, R.113
- Chain D: G.112, T.127
1 PLIP interactions:1 interactions with chain C- Water bridges: C:S.111
PEG.30: 5 residues within 4Å:- Chain D: C.73, D.74, C.75, K.76, P.88
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain C- Water bridges: D:C.73, C:R.544
- 2 x CA: CALCIUM ION(Non-covalent)
CA.32: 6 residues within 4Å:- Chain D: Q.67, D.70, Y.72, D.74, D.80, E.81
6 PLIP interactions:6 interactions with chain D- Metal complexes: D:Q.67, D:D.70, D:Y.72, D:D.74, D:D.80, D:E.81
CA.33: 6 residues within 4Å:- Chain D: R.108, D.111, V.113, D.115, D.121, E.122
6 PLIP interactions:6 interactions with chain D- Metal complexes: D:R.108, D:D.111, D:V.113, D:D.115, D:D.121, D:E.122
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karade, S.S. et al., N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum alpha-Glucosidases I and II with Antiviral Activity. J.Med.Chem. (2021)
- Release Date
- 2021-10-06
- Peptides
- Neutral alpha-glucosidase AB Trypsin-cleaved Fragment #1: A
Neutral alpha-glucosidase AB Trypsin-cleaved Fragment #2: B
Neutral alpha-glucosidase AB Trypsin-cleaved Fragment #3: C
Glucosidase 2 subunit beta: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
HC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.21 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 5 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x WAV: (1S,2S,3R,4S,5S)-1-(hydroxymethyl)-5-{[2-(2-{[2-nitro-4-(triazan-1-yl)phenyl]amino}ethoxy)ethyl]amino}cyclohexane-1,2,3,4-tetrol(Non-covalent)
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karade, S.S. et al., N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum alpha-Glucosidases I and II with Antiviral Activity. J.Med.Chem. (2021)
- Release Date
- 2021-10-06
- Peptides
- Neutral alpha-glucosidase AB Trypsin-cleaved Fragment #1: A
Neutral alpha-glucosidase AB Trypsin-cleaved Fragment #2: B
Neutral alpha-glucosidase AB Trypsin-cleaved Fragment #3: C
Glucosidase 2 subunit beta: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
HC
AD
B